Daniel H. Ahn, DO, MS
GI Medical Oncologist and Associate Professor
Division of Hematology/Medical Oncology
Mayo Clinic
Phoenix, AZ
Daniel H. Ahn, DO, MS is a GI Medical Oncologist and Associate Professor in the Division of Hematology/Medical Oncology at the Mayo Clinic. He conducts clinical and translational research focused on developing anti-cancer agents for patients with gastrointestinal cancers. Dr. Ahn collaborates extensively with various scientists and industry partners to design and execute innovative clinical trials, including many first-in-human studies. He also is the Medical Director for the Clinical Cancer Trials Office and lead for the GI Oncology Translational Research Disease Working Group at Mayo Clinic Arizona. He also serves on the Board of Directors for the Mayo Clinic-supported cancer research consortium Academic and Community Cancer Research United (ACCRU) and is heavily involved in the Alliance for Clinical Trials in Oncology, a National Cancer Institute (NCI)-supported cooperative research group.
Dr. Ahn’s research includes a large focus on the incorporation of agents that target the multiple facets of cancer, including genetic and epigenetic drivers, as well as the feeding microenvironment and the immune milieu. His research has also led to the launch of a number of clinical trials, including recent studies investigating novel agents targeting DNA repair mechanisms in the treatment of hepatobiliary malignancies as well as various targeted therapies in advanced colorectal cancer.
